Trial Profile
Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enalapril (Primary)
- Indications Dilated cardiomyopathy; Heart failure
- Focus Pharmacokinetics
- Acronyms ENADCM; LENA-WP08
- Sponsors Ethicare GmbH
- 20 Sep 2018 This trial has been completed in Hungary.
- 20 Sep 2018 This trial has been completed in Hungary.
- 20 Sep 2018 This trial has been completed in Austria.